Back to Search
Start Over
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
- Source :
- PLoS Pathogens, PLoS Pathogens, Vol 17, Iss 9, p e1009885 (2021)
- Publication Year :
- 2021
- Subjects :
- RNA viruses
Viral Diseases
Coronaviruses
Physiology
Cancer Treatment
Biochemistry
Pearls
Medical Conditions
Immune Physiology
Medicine and Health Sciences
Biology (General)
Pathology and laboratory medicine
Vaccines
Immune System Proteins
Viral Vaccine
Microbial Mutation
Antibodies, Monoclonal
Medical microbiology
Infectious Diseases
Oncology
Viruses
Spike Glycoprotein, Coronavirus
Antibody
SARS CoV 2
Pathogens
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
SARS coronavirus
Infectious Disease Control
medicine.drug_class
QH301-705.5
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunology
Biology
Monoclonal antibody
Microbiology
Antibodies
Antibody Therapy
Virology
Genetics
medicine
Humans
Molecular Biology
SARS
Biology and life sciences
SARS-CoV-2
Organisms
Viral pathogens
Proteins
COVID-19
Genetic Variation
Covid 19
Viral Vaccines
RC581-607
Antibodies, Neutralizing
Microbial pathogens
Monoclonal Antibodies
Immunoglobulin Fc Fragments
biology.protein
Parasitology
Clinical Immunology
Immunologic diseases. Allergy
Clinical Medicine
Antibody therapy
Subjects
Details
- ISSN :
- 15537374
- Volume :
- 17
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- PLoS pathogens
- Accession number :
- edsair.doi.dedup.....bd68c5eaec366b89ae59ff65f64004f9